Tag:

Francis Collins

COVID-19: FDA Likely To Approve Brand-New Time Frame For Booster Shot COVID-19: FDA Likely To Approve Brand-New Time Frame For Booster Shot
Covid-19: FDA Likely To Approve Brand-New Time Frame For Booster Shot The timeline for COVID-19 booster shots may be accelerated as the US Food and Drug Administration (FDA) is expected to approve booster shots for all Americans after six months, not eight, as previously announced. According to reports, as more data is examined by federal health officials, it is more likely that booster shots will be required sooner than later for the Pfizer and Moderna vaccines. Before they can go into arms, the FDA must authorize booster shots for each vaccine. A spokesperson for the agency said that under its general policy it "cannot comment on or confirm the existence" o…
COVID-19: CDC Announces Starting Date For Booster Shots COVID-19: CDC Announces Starting Date For Booster Shots
Covid-19: CDC Announces Starting Date For Booster Shots Federal health officials have set a date for when they plan to begin rolling out COVID-19 booster shots to help curtail the spread of new variants of the virus. Citing new data that showed Pfizer and Moderna vaccines’ effectiveness wanes over time, President Joe Biden’s administration announced that beginning the week of Monday, Sept. 20, booster shots would be made available for many Americans. Earlier story - COVID-19: US Expected To Announce Time Frame For All Americans To Get Booster Shots The Centers for Disease Control and Prevention (CDC) and US Food and Drug Administration (FDA) sa…
COVID-19: US Expected To Announce Time Frame For All Americans To Get Booster Shots COVID-19: US Expected To Announce Time Frame For All Americans To Get Booster Shots
Covid-19: US Expected To Announce Time Frame For All Americans To Get Booster Shots Federal health officials have outlined their plans for when most Americans should get COVID-19 booster shots after becoming fully vaccinated. Pending authorization from the US Food and Drug Administration (FDA), a plan still being developed would advise Americans to get a COVID-19 booster shot eight months after becoming fully vaccinated to help stave off variants of the virus. Both Pfizer and Moderna, two of the three shots currently being administered in the US, have already submitted initial data to the FDA regarding their booster doses of their COVID-19 vaccines and are awaiting appro…
COVID-19: US To Invest $3.2 Billion For Purchase Of Anti-Viral Pills COVID-19: US To Invest $3.2 Billion For Purchase Of Anti-Viral Pills
Covid-19: US To Invest $3.2 Billion For Purchase Of Anti-Viral Pills President Joe Biden’s administration announced the United States is investing $3.2 billion to advance the development of antiviral drugs to treat viruses, including COVID-19. On Thursday, June 17, Biden announced the Antiviral Program for Pandemics, “a government-wide effort to speed up clinical trials of promising candidate drugs and develop next-generation treatments for Covid and other viruses that may cause future pandemics,” according to infectious disease expert Dr. Anthony Fauci. As part of the plan, the National Institutes of Health will “evaluate, prioritize, and advance” antivira…
COVID-19: One Vaccine Dose May Be As Effective As Two For Those Who've Had Virus, Report Says COVID-19: One Vaccine Dose May Be As Effective As Two For Those Who've Had Virus, Report Says
Covid-19: One Vaccine Dose May Be As Effective As Two For Those Who've Had Virus, Report Says New studies have found that Americans receiving the first dose of the two-shot Moderna and Pfizer COVID-19 vaccine may be protected against the spread of the vaccine. According to a Bloomberg report, out of more than 1,000 staff members tested at Cedars-Sinai Medical Center in Los Angeles, many responded to the first dose so robustly that their results were similar to co-workers who received both doses. Research leader Susan Cheng, who co-authored a study published in the Nature Medicine journal, said that those who have already contracted the virus, immune responses after one vaccine have …
COVID-19: High Percentage Of Those Infected With Virus Show No Symptoms, New Research Reveals COVID-19: High Percentage Of Those Infected With Virus Show No Symptoms, New Research Reveals
Covid-19: High Percentage Of Those Infected With Virus Show No Symptoms, New Research Reveals An extraordinarily high percentage of COVID-19 infected people showed no symptoms of the disease, according to new research. Up to 40 percent of infected people "seem to have no symptoms," National Institutes of Health (NIH) Director Francis Collins said. "This might potentially explain why some people seem to fend off the virus and may be less susceptible to becoming severely ill," Collins wrote in a blog post.  Collins said it's "becoming apparent that our country is entering a new and troubling phase of the pandemic as SARS-CoV-2, the novel coronavirus that causes COVID-19, co…
COVID-19: These Factors May Determine Why Virus Spares Some, Kills Others, Report Says COVID-19: These Factors May Determine Why Virus Spares Some, Kills Others, Report Says
Covid-19: These Factors May Determine Why Virus Spares Some, Kills Others, Report Says A new report has examined why the novel coronavirus (COVID-19) spares some and has proven deadly for others. Months into the outbreak of the virus across the globe that broke out stateside in mid-March, scientists continue to investigate COVID-19 to determine how it chooses its victims. According to The Washington Post report, “the research remains provisional or ambiguous, and for now scientists can’t do much better than say that COVID-19 is more likely to be worse for older people — often described as over the age of 60 — and for those with chronic conditions such as …